| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |